VGMEDIUM SIGNALFINANCIAL10-K

VG delivered substantially higher net income while meaningfully reducing R&D expenses, though cash position declined notably amid increased debt levels.

The strong earnings improvement coupled with reduced R&D spending suggests either improved operational efficiency or potential cost-cutting measures that could impact future innovation capacity. The combination of lower cash reserves and higher debt levels indicates increased leverage, which warrants monitoring for financial flexibility implications.

Comparing 2026-03-02 vs 2025-03-06View on EDGAR →
FINANCIAL ANALYSIS

VG's financial profile shows mixed signals with substantially higher profitability driven partly by a 46% reduction in R&D expenses, while total assets expanded 23% alongside a 17% increase in total debt. The company's cash position declined by $1.2 billion to $2.4 billion, representing a more leveraged balance sheet structure. Overall, the results suggest strong near-term earnings performance but raise questions about sustained investment in innovation and optimal capital allocation.

FINANCIAL STATEMENT CHANGES
Net Income
P&L
+53.2%
$1.5B$2.3B

Net income grew 53.2% — bottom-line growth signals improving overall business health.

Inventory
Balance Sheet
+48%
$171.0M$253.0M

Inventory surged 48% — growing faster than typical sales pace; potential demand softening or supply chain overcorrection.

R&D Expense
P&L
-45.8%
$635.0M$344.0M

R&D spending cut 45.8% — could signal cost discipline or concerning reduction in innovation investment.

Cash & Equivalents
Balance Sheet
-34.7%
$3.6B$2.4B

Cash declined 34.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.

Total Assets
Balance Sheet
+22.9%
$43.5B$53.4B

Asset base grew 22.9% — expansion through organic growth, acquisitions, or capital deployment.

Current Liabilities
Balance Sheet
+22.6%
$3.5B$4.3B

Current liabilities rose 22.6% — increased short-term obligations, watch current ratio.

Total Debt
Balance Sheet
+16.8%
$29.3B$34.2B

Debt rose 16.8% — additional borrowing for investment or operations; monitor coverage ratios.

Total Liabilities
Balance Sheet
+16.4%
$35.6B$41.5B

Liabilities increased 16.4% — monitor debt-to-equity ratio and interest coverage.

Current Assets
Balance Sheet
-11.4%
$4.6B$4.0B

Current assets declined 11.4% — monitor working capital adequacy and short-term liquidity.

LANGUAGE CHANGES
NEW — 2026-03-02
PRIOR — 2025-03-06
ADDED
(Exact Name of Registrant as Specified in Its Charter) Delaware 95-3539083 (State or Other Jurisdiction of Incorporation or Organization) (I.R.S.
See the definitions of large accelerated filer, accelerated filer, smaller reporting company and emerging growth company in Rule 12b-2 of the Exchange Act.
7262(b)) by the registered public accounting firm that prepared or issued its audit report.
Market for Registrant s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 102 Item 6.
Management s Discussion and Analysis of Financial Condition and Results of Operations 103 Item 7A.
+7 more — sign up free →
REMOVED
Please click on the OK button below to proceed to the selected site.
Secure .gov websites use HTTPS A lock ( Lock A locked padlock ) or https:// means you ve safely connected to the .gov website.
Share sensitive information only on official, secure websites.
Founded to help our country respond to the Great Depression, we re the agency that protects investors from misconduct, promotes fairness efficiency in the securities markets, and facilitates capital formation for those looking to hire, innovate, and grow.
About the SEC Quick Links We work together to make a positive impact on America s economy, our capital markets, and people s lives.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →